Rheumatology Medical Science Liaison — Field Scientist

6120-Janssen Scientific Affairs, LLC Legal Entity; Horsham (PA); On-site; USD 120,000 - 180,000; Full time

Job summary

Johnson & Johnson Innovative Medicines is seeking a Medical Science Liaison (MSL) in Rheumatology to cover the Georgia and North Florida territory. You will build relationships with Key Opinion Leaders, deliver non-promotional scientific information, and contribute to strategic medical engagements across the region.

You will collaborate with Medical Affairs and R&D, stay current on treatment trends, and travel up to 70% to engage with healthcare professionals and investigators in a compliant,

Qualifications

• Doctorate-level degree or equivalent required (PharmD, PhD, MD, Advanced Practice Providers).
• 2+ years of relevant MSL experience preferred. Board certification for clinical degrees preferred.

Responsibilities

• Develop and implement a scientific engagement plan for the territory.
• Cultivate strong professional relationships with KOLs and healthcare professionals.
• Deliver tailored scientific data and education to healthcare providers.
• Collaborate with internal partners to support Medical Affairs objectives and cross-functional initiatives.
• Identify insights to inform medical strategy and engage in compliant scientific discussions.

Skills

Analytics

Dashboards

Clinical Experience

Clinical Research

Regulations

Cross-Functional Collaboration

Critical Thinking

Communication

Data Analysis

Medical Affairs

Medical Communications

Problem Solving

Relationship Building

Strategic Thinking

Education

Doctorate degree

PharmD/MD/PhD

Job description

Johnson & Johnson Innovative Medicines is seeking a Medical Science Liaison (MSL) in Rheumatology to cover the Georgia and North Florida territory. You will build relationships with Key Opinion Leaders, deliver non-promotional scientific information, and contribute to strategic medical engagements across the region.

You will collaborate with Medical Affairs and R&D, stay current on treatment trends, and travel up to 70% to engage with healthcare professionals and investigators in a compliant,